SARS-CoV-2 Spike RBD Nanobody

Size

100ul

Clone Number

A1

Aliases

S, S1, S1-RBD, Spike glycoprotein

Immunogen Species

Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)

UniProt ID

P0DTC2

Immunogen

Recombinant Human Novel Coronavirus Spike glycoprotein(S) (319-541aa) (CSB-YP3324GMY1 and CSB-MP3324GMY1b1)

Raised in

Species Reactivity

Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)

Tested Applications

ELISA, GICA, Neutralising; Recommended dilution: ELISA:1:10000-1:100000, GICA:1:10000-1:40000, Neutralising:1:100-1:10000

Background

Recombinant anti-SARS-CoV-2 spike VHH is expressed from 293 cells (HEK293) with a human IgG1 Fc tag on C-terminal.

Clonality

Monoclonal

Isotype

VHH fusion with human IgG1 Fc

Purification Method

Affinity-chromatography

Conjugate

Non-conjugated

Buffer

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4

Form

Liquid

Stroage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Names

S

Research Areas

Microbiology